PCLCX vs. QGRPX

Last updated Jun 5, 2026

PCLCX (PACE Large Co Growth Equity Investments) and QGRPX (UBS US Quality Growth At Reasonable Price Fund) are both Large Cap Growth Equities funds from UBS. Over the past 5 years, PCLCX returned 9.79%/yr vs 11.92%/yr for QGRPX. With a 0.95 correlation, they move nearly in lockstep. PCLCX charges 0.88%/yr vs 0.50%/yr for QGRPX.

Performance

PCLCX vs. QGRPX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in PACE Large Co Growth Equity Investments (PCLCX) and UBS US Quality Growth At Reasonable Price Fund (QGRPX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, PCLCX achieves a 3.65% return, which is significantly higher than QGRPX's 2.72% return.

PCLCX

• 1D: -0.93%
• 1M: 4.41%
• YTD: 3.65%
• 6M: 2.47%
• 1Y: 13.18%
• 3Y*: 18.48%
• 5Y*: 9.79%
• 10Y*: 14.77%

QGRPX

• 1D: -1.33%
• 1M: 3.55%
• YTD: 2.72%
• 6M: 1.92%
• 1Y: 15.64%
• 3Y*: 19.96%
• 5Y*: 11.92%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

PCLCX vs. QGRPX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
PCLCX PACE Large Co Growth Equity Investments	3.65%	9.86%	28.05%	35.17%	-28.18%	20.18%	20.08%
QGRPX UBS US Quality Growth At Reasonable Price Fund	2.72%	15.51%	25.13%	35.52%	-25.57%	29.14%	14.62%

Correlation

The correlation between PCLCX and QGRPX is 0.94, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.94
Correlation (3Y) Calculated over the trailing 3-year period	0.95
Correlation (5Y) Calculated over the trailing 5-year period	0.96
Correlation (All Time) Calculated using the full available price history since Jul 10, 2020	0.95

The correlation between PCLCX and QGRPX has been stable across timeframes, ranging from 0.94 to 0.96 - a consistent structural relationship.

Return for Risk

PCLCX vs. QGRPX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PCLCX

PCLCX Risk / Return Rank: 12
PCLCX Sharpe Ratio Rank: 15
PCLCX Sortino Ratio Rank: 14
PCLCX Omega Ratio Rank: 14
PCLCX Calmar Ratio Rank: 9
PCLCX Martin Ratio Rank: 9

QGRPX

QGRPX Risk / Return Rank: 15
QGRPX Sharpe Ratio Rank: 18
QGRPX Sortino Ratio Rank: 18
QGRPX Omega Ratio Rank: 17
QGRPX Calmar Ratio Rank: 11
QGRPX Martin Ratio Rank: 12

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PCLCX vs. QGRPX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for PACE Large Co Growth Equity Investments (PCLCX) and UBS US Quality Growth At Reasonable Price Fund (QGRPX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	PCLCX	QGRPX	Difference
Sharpe ratio: Return per unit of total volatility	1.04	1.22	-0.17
Sortino ratio: Return per unit of downside risk	1.51	1.76	-0.26
Omega ratio: Gain probability vs. loss probability	1.19	1.22	-0.03
Calmar ratio: Return relative to maximum drawdown	0.86	1.02	-0.16
Martin ratio: Return relative to average drawdown	2.47	3.23	-0.76
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

PCLCX vs. QGRPX - Sharpe Ratio Comparison

The current PCLCX Sharpe Ratio is 1.04, which is comparable to the QGRPX Sharpe Ratio of 1.22. The chart below compares the historical Sharpe Ratios of PCLCX and QGRPX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	PCLCX	QGRPX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.04	1.22	-0.17
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.27	0.62	-0.35
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.48	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.37	0.76	-0.39

Drawdowns

PCLCX vs. QGRPX - Drawdown Comparison

The maximum PCLCX drawdown since its inception was -63.98%, which is greater than QGRPX's maximum drawdown of -30.28%. Use the drawdown chart below to compare losses from any high point for PCLCX and QGRPX.

Drawdown Indicators

	PCLCX	QGRPX	Difference
Max Drawdown Largest peak-to-trough decline	-63.98%	-30.28%	-33.70%
Max Drawdown (1Y) Largest decline over 1 year	-17.06%	-17.45%	+0.39%
Max Drawdown (3Y) Largest decline over 3 years	-21.26%	-21.03%	-0.23%
Max Drawdown (5Y) Largest decline over 5 years	-38.81%	-30.28%	-8.53%
Max Drawdown (10Y) Largest decline over 10 years	-38.81%	—	—
Current Drawdown Current decline from peak	-1.31%	-1.94%	+0.63%
Average Drawdown Average peak-to-trough decline	-20.34%	-7.56%	-12.78%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.73%	5.29%	+0.44%

Volatility

PCLCX vs. QGRPX - Volatility Comparison

PACE Large Co Growth Equity Investments (PCLCX) and UBS US Quality Growth At Reasonable Price Fund (QGRPX) have volatilities of 3.44% and 3.51%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	PCLCX	QGRPX	Difference
Volatility (1M) Calculated over the trailing 1-month period	3.44%	3.51%	-0.07%
Volatility (6M) Calculated over the trailing 6-month period	11.15%	11.77%	-0.62%
Volatility (1Y) Calculated over the trailing 1-year period	14.09%	14.60%	-0.51%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	36.92%	19.61%	+17.31%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	30.98%	19.30%	+11.68%

PCLCX vs. QGRPX - Expense Ratio Comparison

PCLCX has a 0.88% expense ratio, which is higher than QGRPX's 0.50% expense ratio.

Dividends

PCLCX vs. QGRPX - Dividend Comparison

PCLCX's dividend yield for the trailing twelve months is around 19.93%, more than QGRPX's 6.00% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
PCLCX PACE Large Co Growth Equity Investments	19.93%	20.66%	11.94%	2.09%	60.17%	22.81%	18.38%	16.53%	22.05%	10.32%	3.30%	17.60%
QGRPX UBS US Quality Growth At Reasonable Price Fund	6.00%	6.16%	3.62%	0.42%	1.00%	2.84%	0.37%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both PCLCX and QGRPX in my portfolio?

With a correlation of 0.94, PCLCX and QGRPX move almost identically. Holding both adds very little diversification - you're essentially doubling your position in the same market segment. Choosing one is usually more capital-efficient.

Which is riskier, PCLCX or QGRPX?

QGRPX has higher volatility (3.51%) compared to PCLCX (3.44%). In terms of maximum drawdown, PCLCX dropped -63.98% vs QGRPX's -30.28%.

Which has better risk-adjusted returns?

QGRPX currently has the higher Sharpe Ratio (1.22 vs 1.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.